BioSpace News Archive

BioMidwest

Abeona Announces Pricing of Public Offering of Common Stock and Pre‑Funded Warrants

Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced the pricing of its public offering of 26,982,945 shares of its common stock at a public offering price of $2.50 per share and in lieu of common stock,

December 20, 2019
·
5 min read
Business

Bioclinica Announces Senior Leadership Change

Bioclinica, a leading provider of clinical science and technology expertise to assist the life science industry, today announces that David Herron, Bioclinica’s President and Chief Executive Officer, will be leaving the company to pursue other business interests.

December 20, 2019
·
1 min read
Business

Three Invacare Board Members Recognized by WomenInc. as Most Influential Corporate Directors

Invacare Corporation (NYSE: IVC) announced today that three members of its Board of Directors have been named to WomenInc. Magazine’s list of 2019 Most Influential Corporate Directors.

December 20, 2019
·
4 min read
Business

NORD Announces Two New Board Members

The National Organization for Rare Disorders (NORD)®, the leading independent nonprofit organization representing over 25 million Americans with rare diseases, announces the appointment of two new members to its Board of Directors, effective immediately.

December 20, 2019
·
4 min read
BioCapital

FDA, DEA seize 44 websites advertising sale of illicit THC vaping cartridges to US consumers as part of Operation Vapor Lock

The U.S. Food and Drug Administration and the Drug Enforcement Administration (DEA) announced today that they have seized 44 websites advertising the sale of illicit vaping cartridges containing tetrahydrocannabinol (THC), the primary psychoactive component of the cannabis plant.

December 20, 2019
·
4 min read
Drug Development

Longeveron LLC Announces Completion of Enrollment in Phase 1 Clinical Trial of Longeveron Allogeneic Mesenchymal Stem Cells (LMSCs) in Alzheimer’s Disease.

Longeveron LLC, a leading developer of adult stem cell technologies for chronic, aging-related and life-threatening conditions, announced today that it has completed enrollment in its Phase 1 Alzheimer’s disease trial

December 20, 2019
·
2 min read
Patent Approved in Japan for Isofol’s Drug Candidate Arfolitixorin

Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL). A patent covering the Active Pharmaceutical Ingredient (API), arfolitixorin hemisulfate, in Isofol’s drug candidate has been approved by the the Japanense Patent Office.

December 20, 2019
·
4 min read
Business

Hill-Rom Holdings, Inc., Nominates Felicia Norwood To Stand for Election to Its Board of Directors

Hillrom (NYSE: HRC) today announced that its board of directors has nominated Felicia Norwood to stand for election as a director at the company’s Annual Meeting of Shareholders on February 25, 2020.

December 20, 2019
·
4 min read
Compugen Added to the NASDAQ Biotechnology Index

Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that it has been selected for addition to the NASDAQ Biotechnology Index® (NASDAQ: ^NBI).

December 20, 2019
·
3 min read
Business

Ariette van Strien Named President of Marken

Following the press release on December 3rd from UPS and Marken announcing that Wes Wheeler has been appointed President of UPS’s global Healthcare and Life Sciences unit, Marken announced that Ariette van Strien has been named as President of Marken.

December 20, 2019
·
2 min read